Erschienen in:
01.12.2015 | Original Article
Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy
verfasst von:
Kentaro Nakai, Hideki Fujii, Mikiko Yoshikawa, Keiji Kono, Yuriko Yonekura, Shunsuke Goto, Takeshi Ishimura, Masashi Takeda, Masato Fujisawa, Shinichi Nishi
Erschienen in:
Clinical and Experimental Nephrology
|
Ausgabe 6/2015
Einloggen, um Zugang zu erhalten
Abstract
Background
Cinacalcet is a promising therapy widely used in dialysis patients with hyperparathyroidism resistant to conventional therapy. However, reports regarding the influence of cinacalcet cessation after long-term use on kidney transplantation patients are few.
Methods
This retrospective observational study included 40 dialysis patients who underwent kidney transplantation. Creatinine, corrected calcium, phosphorus, alkaline phosphatase, and intact parathyroid hormone levels were assessed before and after kidney transplantation according to pretransplant treatment of chronic kidney disease–mineral and bone disorder.
Results
Ultrasonography revealed enlargement of the parathyroid in all patients treated with cinacalcet. Although the data at the time of kidney transplantation were comparable, the serum levels of calcium, alkaline phosphatase, and intact parathyroid hormone after kidney transplantation were higher in patients treated with cinacalcet than in those treated without. However, serum phosphate levels in the cinacalcet group were slightly higher at the time of kidney transplantation and significantly lower 3 months later.
Conclusions
Mineral abnormalities persisted in kidney transplant patients with enlarged parathyroid glands after discontinuation of cinacalcet treatment. Parathyroidectomy should be considered in kidney transplant candidates with the risk of developing refractory hyperparathyroidism after transplantation.